The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clinically validated targets. Recently, novel kinase targets that are uncharacterized have emerged from genome sequencing and RNAi studies. Chemical probes are urgently needed to functionally annotate these kinases and to stimulate new drug discovery efforts.
References
Nakano, H. et al. J. Antibiot. (Tokyo) 40, 706–708 (1987).
Janne, P.A., Gray, N. & Settleman, J. Nat. Rev. Drug Discov. 8, 709–723 (2009).
Lackey, K.E. Curr. Top. Med. Chem. 6, 435–460 (2006).
Fabian, M.A. et al. Nat. Biotechnol. 23, 329–336 (2005).
Fedorov, O. et al. Proc. Natl. Acad. Sci. USA 104, 20523–20528 (2007).
Karaman, M.W. et al. Nat. Biotechnol. 26, 127–132 (2008).
Walker, I. & Newell, H. Nat. Rev. Drug Discov. 8, 15–16 (2009).
Wood, L.D. et al. Science 318, 1108–1113 (2007).
Lin, J. et al. Genome Res. 17, 1304–1318 (2007).
Vieth, M., Sutherland, J.J., Robertson, D.H. & Campbell, R.M. Drug Discov. Today 10, 839–846 (2005).
Bain, J. et al. Biochem. J. 408, 297–315 (2007).
Bamborough, P., Drewry, D., Harper, G., Smith, G.K. & Schneider, K. J. Med. Chem. 51, 7898–7914 (2008).
Beerenwinkel, N. et al. PLoS Comput. Biol. 3, e225 (2007).
Torkamani, A. & Schork, N.J. Cancer Res. 68, 1675–1682 (2008).
Torkamani, A., Verkhivker, G. & Schork, N.J. Cancer Lett. 281, 117–127 (2009).
Gibson, T.J. Trends Biochem. Sci. 34, 471–482 (2009).
Janes, K.A., Reinhardt, H.C. & Yaffe, M.B. Cell 135, 343–354 (2008).
Moffat, J. et al. Cell 124, 1283–1298 (2006).
Baldwin, A. et al. Proc. Natl. Acad. Sci. USA 105, 16478–16483 (2008).
Bommi-Reddy, A. et al. Proc. Natl. Acad. Sci. USA 105, 16484–16489 (2008).
Grueneberg, D.A. et al. Proc. Natl. Acad. Sci. USA 105, 16472–16477 (2008).
Grueneberg, D.A. et al. Proc. Natl. Acad. Sci. USA 105, 16490–16495 (2008).
Manning, B.D. Sci. Signal. 2, pe15 (2009).
Turner, N.C. et al. EMBO J. 27, 1368–1377 (2008).
Scholl, C. et al. Cell 137, 821–834 (2009).
Weiss, W.A., Taylor, S.S. & Shokat, K.M. Nat. Chem. Biol. 3, 739–744 (2007).
Davies, S.P., Reddy, H., Caivano, M. & Cohen, P. Biochem. J. 351, 95–105 (2000).
Zhang, J., Yang, P.L. & Gray, N.S. Nat. Rev. Cancer 9, 28–39 (2009).
Liu, Y. & Gray, N.S. Nat. Chem. Biol. 2, 358–364 (2006).
Marsden, B.D. & Knapp, S. Curr. Opin. Chem. Biol. 12, 40–45 (2008).
Adrian, F.J. et al. Nat. Chem. Biol. 2, 95–102 (2006).
Ohren, J.F. et al. Nat. Struct. Mol. Biol. 11, 1192–1197 (2004).
Engel, M. et al. EMBO J. 25, 5469–5480 (2006).
Hindie, V. et al. Nat. Chem. Biol. 5, 758–764 (2009).
Barnett, S.F. et al. Biochem. J. 385, 399–408 (2005).
Manning, G., Whyte, D.B., Martinez, R., Hunter, T. & Sudarsanam, S. Science 298, 1912–1934 (2002).
Greenman, C. et al. Nature 446, 153–158 (2007).
Tecle, H. et al. Bioorg. Med. Chem. Lett. 19, 226–229 (2009).
Nagar, B. et al. Cell 112, 859–871 (2003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Fedorov, O., Müller, S. & Knapp, S. The (un)targeted cancer kinome. Nat Chem Biol 6, 166–169 (2010). https://doi.org/10.1038/nchembio.297
Issue Date:
DOI: https://doi.org/10.1038/nchembio.297
- Springer Nature America, Inc.
This article is cited by
-
Integrative proteomic characterization of trace FFPE samples in early-stage gastrointestinal cancer
Proteome Science (2022)
-
Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis
Nature Communications (2020)
-
Synthesis and biological evaluation of selected 7-azaindole derivatives as CDK9/Cyclin T and Haspin inhibitors
Medicinal Chemistry Research (2020)
-
Discovery of a selective inhibitor of doublecortin like kinase 1
Nature Chemical Biology (2020)
-
A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives
Scientific Reports (2019)